| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-56 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
| filingDate |
1999-04-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2002-05-08^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002512784-A |
| titleOfInvention |
Method for producing doxorubicin |
| abstract |
(57) A set comprising a DNA molecule comprising a DNA region or fragment containing the gene doxA encoding daunorubicin 14-hydroxylase, and a region or fragment containing one or more genes that confer resistance to daunorubicin and doxorubicin By transforming host cells with the recombinant vector, the ability to convert daunorubicin to doxorubicin can be improved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5422387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009035107-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383392-B2 |
| priorityDate |
1998-04-24^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |